Address
Shire PLC
5 Riverwalk
Citywest Business Campus
Dublin
Co. Dublin
Ireland
Website
Business classification
VCID: 14395711
Profile
Corporate information
Official name
Shire PLC
Registration country
Official name
Shire PLC
Registration country
Investment activity status
Active investor
Overview
Shire enables people with life-altering conditions to lead better lives. Shire's strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. Shire's focus is on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.
Funding
Funding rounds
(8 Jan 2019) Change in valuation: unknown
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Takeda Pharmaceutical Co Ltd | Initial investment. Led the round. |
Acquisition USD 54,800,000,000
USD 54,800,000,000 (18 Jul 2014) at USD 54,800,000,000 valuation.
ABANDONED
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Abbvie Inc | United States | USD 54,800,000,000 (USD 54,800,000,000). Initial investment. Round participant. |
Cap Table
Current and past shareholders
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
ViroPharma Inc Provider of life-saving medicines for life-threatening diseases. |
United States | 10 Nov 2013 | Acquisition USD 4,200,000,000 (USD 4,200,000,000) deal size. Initial investment. Led the investment round. Active |